Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Miromatrix Medical Inc. (MIRO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 52.4% | 1512.1% | 1074.6% | 100.0% |
| Gross profit | 47.6% | -1412.1% | -974.6% | 0.0% |
| Selling, general and administrative | 914.5% | 14043.0% | 4533.0% | |
| Research and development | 1919.7% | 32528.8% | 15647.5% | 2506.7% |
| General and administrative | | | | 974.4% |
| EBITDA | -3068.4% | -51475.0% | -26749.6% | -3869.0% |
| Depreciation | 116.3% | 507.8% | 366.1% | 137.7% |
| EBIT | -3184.6% | -51306.4% | -22047.2% | -3596.7% |
| Pre-tax income | -3142.2% | -44368.1% | -22156.8% | -3400.7% |
| Income taxes | 0.0% | 0.0% | 0.0% | -1782.0% |
| Net income | -3142.2% | -44368.1% | -22156.8% | -1618.7% |
|